NCT01554670

Brief Summary

The purpose of this study is to determine whether radio-frequency (RF)-based plasma micro-tenotomy has a positive effective for the treatment of shoulder impingement syndrome with cuff tendinosis. Eighty patients with impingement syndrome and cuff tendinosis that treated arthroscopic were enrolled in the study. Patients were randomly assigned to receive either arthroscopic subacromial decompression alone (ASD group, n=40) or arthroscopic subacromial decompression combined with RF-based plasma micro-tenotomy (RF group, n=40). Clinical outcome data including VAS(Visual Analogue Scale) pain score, Shoulder range of motion (ROM), ASES(American Shoulder And Elbow Surgeons) score, UCLA(University of California, Los Angeles) score, Constant-Murley score and SST(Simple Shoulder Test) score were recorded preoperatively and at postoperative 3-week, 6-week, 3-month, 6-month and 1-year.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2009

Typical duration for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 1, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 15, 2012

Completed
Last Updated

March 20, 2012

Status Verified

March 1, 2012

Enrollment Period

1.9 years

First QC Date

March 1, 2012

Last Update Submit

March 18, 2012

Conditions

Keywords

Arthroscopic subacromial decompressionBipolar radiofrequencyTendon debridementShoulder surgery

Outcome Measures

Primary Outcomes (1)

  • VAS pain score

    postoperative 3-week

Secondary Outcomes (5)

  • Shoulder range of motion (ROM)

    3-month, 6-month, 1-year

  • ASES score

    3-month, 6-month, 1-year

  • UCLA score

    UCLA score

  • Constant-Murley score

    3-month, 6-month, 1-year

  • SST score

    3-month, 6-month, 1-year

Study Arms (2)

arthroscopic subacromial decompression

NO INTERVENTION

A thorough subacromial decompression was performed as described by Neer (which include coracoacromial ligament resection, excision of the anterio-lateral tip of the acromion and thorough debridement of the bursa).

decompression+RF micro-tenotomy

ACTIVE COMPARATOR

A thorough subacromial decompression was performed as described by Neer (which include coracoacromial ligament resection, excision of the anterio-lateral tip of the acromion and thorough debridement of the bursa).an additional bipolar RF-based device (TOPAZ, Arthrocare, Austin, TX) connected to a System2000 generator (Arthrocare, Austin, TX) was used to perform the micro-tenotomy. The device functions using a controlled plasma-mediated RF-based process (Co-ablation).The device was placed on the tendon perpendicular to its surface, for 500 milliseconds, and micro-debridement was performed at 5-mm intervals by a 2-row fashion, which covered most of the foot-print region of the supraspinatous tendon and at a depth of 3 to 5 mm

Procedure: RF micro-tenotomy

Interventions

an additional bipolar RF-based device (TOPAZ, Arthrocare, Austin, TX) connected to a System2000 generator (Arthrocare, Austin, TX) was used to perform the micro-tenotomy. The device functions using a controlled plasma-mediated RF-based process (Co-ablation).The device was placed on the tendon perpendicular to its surface, for 500 milliseconds, and micro-debridement was performed at 5-mm intervals by a 2-row fashion, which covered most of the foot-print region of the supraspinatous tendon and at a depth of 3 to 5 mm

Also known as: RF-based plasma micro-tenotomy
decompression+RF micro-tenotomy

Eligibility Criteria

Age26 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a skeletally mature patient who agreed to participate in the study
  • shoulder impingement syndrome was diagnosed by one senior surgeon (CYJ) and without any sign of rotator cuff tear both on pre-operative MRI or intra-operative arthroscopic view
  • supraspinatous tendinosis was confirmed on preoperative MRI
  • the symptoms were not relieved by a standardized conservative treatment regime
  • patient underwent standard arthroscopic subacromial decompression surgery.

You may not qualify if:

  • any concomitant partial or full-thickness rotator cuff tear verified both on pre-operative MRI or intra-operative finding
  • concomitant biceps lesions or internal impingement
  • any history of surgical treatment on the same shoulder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Chunyan Jiang, MD, PhD

    Beijing JST Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy director of the physician

Study Record Dates

First Submitted

March 1, 2012

First Posted

March 15, 2012

Study Start

January 1, 2009

Primary Completion

December 1, 2010

Study Completion

February 1, 2011

Last Updated

March 20, 2012

Record last verified: 2012-03